Gyre Therapeutics
GYRE
GYRE
35 hedge funds and large institutions have $39.7M invested in Gyre Therapeutics in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2.53% more ownership
Funds ownership: 4.13% → 6.66% (+2.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
35
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$6.14M | |
| 2 | +$5.46M | |
| 3 | +$4.24M | |
| 4 |
VMI
VHCP Management II
New York
|
+$3.21M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$1.7M |
Top Sellers
| 1 | -$2.99M | |
| 2 | -$220K | |
| 3 | -$47.9K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.7K |
| 5 |
FMA
FNY Managed Accounts
New York
|
-$2K |